Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

BMS-470539 reduces skin fibrosis and inflammation.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

DFMO may help control hair growth and treat cancer.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

The document concluded that certain compounds might strongly bind to and potentially inhibit a key SARS-CoV-2 protein, but further testing is needed.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

A new compound shows promise as a topical treatment for hair loss.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Tadalafil and Finasteride may help treat aggressive melanoma.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.